2[1]Enneking WF.Modification of the system for functional evaluation of surgical management of musouloskeletal tumors.In:Enneking WF.Limb salvage in musculoskeletal oncology.New York:Churchill,1987:626-639.
3[2]Mankin HJ,Lange TA,Spanier SS.The hazards of biopsy in patients with malignant primary bone and soft tissue tumors.J Bone Joint Surg,1982,64A:1121-1127.
4[3]Mankin HJ,Mankin CJ,Simon MA.The hazards of biopsy,revisited.J Bone Joint Surg,1996,78A:656-663.
5[5]Simon MA.Current concepts review:Biopsy of musculoskeletal tumors.J Bone Joint Surg,1982,64A:1253-1257.
6[6]Chang AE,Sondak VK.Clinical evaluation and treatment of soft tissue tumors.In:Enzinger FM,Weiss SW.Soft tissue Tumors.St Louis,CV Mosby,1995:17-138.
7[7]Davies NM,Livesly PJ,Cannon SR.Recurrence of an osteosarcoma in a needle biopsy tract.J Bone Joint Surg,1993,75B:977-978.
8[8]Noria S,Davis A,Kandel R,et al.Residual disease following unplanned excision of soft-tissue sarcoma of an extremity.J Bone Joint Surg,1996,78A:650-655.
9[9]Schwartz HS,Spengler DM.Needle tract recurrences after closed biopsy for sarcomas:Three cases and review of the literature.Ann Surg Oncol,1997,4:228-236.
10Simon MA.Current concepts review:biopsy of musculoskeletal tumors[J].J Bone Joint Surg,1982,64A:1253-1257.